Bosch RJ - Search Results

1

Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort.

Smurzynski M, Wu K, Letendre S, Robertson K, Bosch RJ, Clifford DB, Evans S, Collier AC, Taylor M, Ellis R. Smurzynski M, et al. Among authors: bosch rj. AIDS. 2011 Jan 28;25(3):357-65. doi: 10.1097/QAD.0b013e32834171f8. AIDS. 2011. PMID: 21124201 Free PMC article.

2

Considerations in choosing a primary endpoint that measures durability of virological suppression in an antiretroviral trial.

Gilbert PB, Ribaudo HJ, Greenberg L, Yu G, Bosch RJ, Tierney C, Kuritzkes DR. Gilbert PB, et al. Among authors: bosch rj. AIDS. 2000 Sep 8;14(13):1961-72. doi: 10.1097/00002030-200009080-00012. AIDS. 2000. PMID: 10997401

3

Association of T cell proliferative responses and phenotype with virus control in chronic progressive HIV-1 disease.

Malhotra U, Bosch RJ, Chan E, Wang R, Fischl MA, Collier AC, McElrath MJ. Malhotra U, et al. Among authors: bosch rj. J Infect Dis. 2004 Feb 1;189(3):515-9. doi: 10.1086/381038. Epub 2004 Jan 16. J Infect Dis. 2004. PMID: 14745710 Clinical Trial.

4

Effect of adjunct hydroxyurea on helper T cell immunity in HIV type 1-infected patients with virological suppression.

Malhotra U, Bosch RJ, Wang R, Collier A, McElrath MJ. Malhotra U, et al. Among authors: bosch rj. AIDS Res Hum Retroviruses. 2004 Aug;20(8):807-12. doi: 10.1089/0889222041725226. AIDS Res Hum Retroviruses. 2004. PMID: 15320983 Clinical Trial.

5

Long-term changes in circulating CD4 T lymphocytes in virologically suppressed patients after 6 years of highly active antiretroviral therapy.

Smith K, Aga E, Bosch RJ, Valdez H, Connick E, Landay A, Kuritzkes D, Gross BH, Francis IR, McCune JM, Kessler H, Lederman M. Smith K, et al. Among authors: bosch rj. AIDS. 2004 Sep 24;18(14):1953-6. doi: 10.1097/00002030-200409240-00012. AIDS. 2004. PMID: 15353982

6

Pretreatment factors associated with 3-year (144-week) virologic and immunologic responses to potent antiretroviral therapy.

Bosch RJ, Bennett K, Collier AC, Zackin R, Benson CA. Bosch RJ, et al. J Acquir Immune Defic Syndr. 2007 Mar 1;44(3):268-77. doi: 10.1097/QAI.0b013e31802c7e20. J Acquir Immune Defic Syndr. 2007. PMID: 17146370 Clinical Trial.

7

Changes in the slope of the CD4 cell count increase after initiation of potent antiretroviral treatment.

Bosch RJ, Wang R, Vaida F, Lederman MM, Albrecht MA. Bosch RJ, et al. J Acquir Immune Defic Syndr. 2006 Dec 1;43(4):433-5. J Acquir Immune Defic Syndr. 2006. PMID: 17183628 Clinical Trial.

8

The prevalence and incidence of neurocognitive impairment in the HAART era.

Robertson KR, Smurzynski M, Parsons TD, Wu K, Bosch RJ, Wu J, McArthur JC, Collier AC, Evans SR, Ellis RJ. Robertson KR, et al. Among authors: bosch rj. AIDS. 2007 Sep 12;21(14):1915-21. doi: 10.1097/QAD.0b013e32828e4e27. AIDS. 2007. PMID: 17721099

9

Suppression of HIV-1 replication by antiretroviral therapy improves renal function in persons with low CD4 cell counts and chronic kidney disease.

Kalayjian RC, Franceschini N, Gupta SK, Szczech LA, Mupere E, Bosch RJ, Smurzynski M, Albert JM. Kalayjian RC, et al. Among authors: bosch rj. AIDS. 2008 Feb 19;22(4):481-7. doi: 10.1097/QAD.0b013e3282f4706d. AIDS. 2008. PMID: 18301060 Free PMC article. Clinical Trial.

10

AIDS clinical trials group longitudinal linked randomized trials (ALLRT): rationale, design, and baseline characteristics.

Smurzynski M, Collier AC, Koletar SL, Bosch RJ, Wu K, Bastow B, Benson CA. Smurzynski M, et al. Among authors: bosch rj. HIV Clin Trials. 2008 Jul-Aug;9(4):269-82. doi: 10.1310/hct0904-269. HIV Clin Trials. 2008. PMID: 18753121 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

411 results

Search Page

Filters